Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Clinical Pharmacokinetics|May 1, 2007
Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical responseMassimo C Mauri, Lucia S Volonteri, Alessandro Colasanti, et al.Clinical Drug Investigation|February 4, 2012
Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational studyA Carlo Altamura, Donatella Moliterno, Silvia Paletta, et al.Journal of Clinical Psychopharmacology|November 19, 2003
Predictors of clinical outcome in schizophrenic patients responding to clozapineMassimo C Mauri, Lucia S Volonteri, Bernardo Dell'Osso, et al.CNS Spectrums|February 5, 2019
Aggressiveness and violence in psychiatric patients: a clinical or social paradigm?Massimo C Mauri, Giovanna Cirnigliaro, Chiara Di Pace, et al.Journal of Clinical Psychopharmacology|June 19, 2018
Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable FormulationSara Baldelli, Massimo C Mauri, Chiara Di Pace, et al.International Journal of Psychiatry in Clinical Practice|December 31, 2014
"Long-acting" olanzapine in maintenance therapy of schizophrenia: A study with plasma levelsMassimo C Mauri, Michele Maffini, Chiara Di Pace, et al.Human Psychopharmacology|July 15, 2003
Long-term efficacy and therapeutic drug monitoring of sertraline in major depressionMassimo C Mauri, Alessio Fiorentini, Giancarlo Cerveri, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-upGiovanni M Ruggiero, Massimo C Mauri, Anna C Omboni, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Clinical outcome and tolerability of sertraline in major depression: a study with plasma levelsMassimo C Mauri, Valerio Laini, Giancarlo Cerveri, et al.Therapeutic Drug Monitoring|May 10, 2017
Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational StudyChiara Rovera, Massimo C Mauri, Chiara Di Pace, et al.Pageof 3